Filing Details
Beam Therapeutics Inc. (NASDAQ:BEAM) filed a Form 8-K with the Securities and Exchange Commission on November 03, 2026, disclosing a material event.
8k filedNASDAQ:BEAM
Beam Therapeutics Inc. (BEAM) Reports Material Event to SEC
Beam Therapeutics Inc. (NASDAQ:BEAM) filed a Form 8-K with the Securities and Exchange Commission on November 03, 2026, disclosing a material event.
At publication ·
What changed
Beam Therapeutics Inc. (NASDAQ:BEAM) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Beam Therapeutics filed a Form 8-K on November 3, 2026, disclosing a material event that shareholders should know about.
- The stock traded at $25.87 with a market capitalization of $2.8 billion at the time of the filing.
- The article does not specify the nature of the material event, which could involve leadership changes, agreements, acquisitions, or financial guidance changes.
Market Context
Beam Therapeutics Inc.'s stock currently trades at $25.87 with a market capitalization of $2.8B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Beam Therapeutics Inc.'s stock.
All SEC filings for Beam Therapeutics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BEAM Stock Page
Frequently Asked Questions
Where can I read BEAM's SEC filings?
Browse all filings on our BEAM SEC filings page.
What types of SEC filings does Beam Therapeutics Inc. file?
Public companies like Beam Therapeutics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
